Letrozole 2.5mg trials for Breast cancer

All Letrozole 2.5mg trials · All Breast cancer trials

Phase breakdown

Recruiting trials studying Letrozole 2.5mg for Breast cancer

• Different Doses of Dalpicicl Combined With Letrozole in the First-line Treatment of HR-positive, HER2-negative Advanced Breast Cancer
  NCT07285382 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: Female · 2 locations
• Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA)
  NCT05512364 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 112 locations
• Impact of Omitting Chemo Based on Patient's Selection for ER-Positive, HER2-Negative Breast Cancer With Ribociclib and Endocrine Therapy
  NCT06953882 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials study Letrozole 2.5mg for Breast cancer?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.